PLX
USDProtalix BioTherapeutics Inc. (DE) Common Stock
$2.340+0.030 (1.299%)
Real-time Price
Healthcare
Biotechnology
United States
Price Chart
Loading Chart...
Key Metrics
Market Metrics
Open
$2.310
High
$2.375
Low
$2.260
Volume
0.48M
Company Fundamentals
Market Cap
186.6M
Industry
Biotechnology
Country
United States
Trading Stats
Avg Volume
0.83M
Exchange
ASE
Currency
USD
52-Week Range
Low $1.16Current $2.340High $3.1
Related News
GlobeNewswire
Chiesi Global Rare Diseases and Protalix BioTherapeutics Seek Re-examination from the EMA for the Negative Opinion for Elfabrio (pegunigalsidase alfa) Alternative Dosing Regimen of Every Four Weeks in the EU
PARMA, Italy and CARMIEL, Israel, Nov. 03, 2025 (GLOBE NEWSWIRE) -- Chiesi Global Rare Diseases, a business unit of the Chiesi Group, and Protalix BioTherapeutics, Inc. (NYSE:PLX), have requested a re-examination of
View more
PR Newswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Protalix BioTherapeutics, Inc. - PLX
Pomerantz LLP is investigating claims on behalf of investors of Protalix BioTherapeutics, Inc. ("Protalix" or the "Company") (NYSE: PLX). Such...
View more
Related Stocks
Stay Updated
Set price alerts, get AI analysis updates and real-time market news.